Found: 51
Select item for more details and to access through your institution.
Fimepinostat (CUDC‐907) in patients with relapsed/refractory diffuse large B cell and high‐grade B‐cell lymphoma: report of a phase 2 trial and exploratory biomarker analyses.
- Published in:
- British Journal of Haematology, 2021, v. 195, n. 2, p. 201, doi. 10.1111/bjh.17730
- By:
- Publication type:
- Article
Clinical heterogeneity of diffuse large B cell lymphoma following failure of front-line immunochemotherapy.
- Published in:
- British Journal of Haematology, 2017, v. 179, n. 1, p. 50, doi. 10.1111/bjh.14813
- By:
- Publication type:
- Article
Risk of histological transformation and therapy-related myelodysplasia/acute myeloid leukaemia in patients receiving radioimmunotherapy for follicular lymphoma.
- Published in:
- British Journal of Haematology, 2017, v. 178, n. 3, p. 427, doi. 10.1111/bjh.14688
- By:
- Publication type:
- Article
A phase II trial of RCHOP followed by radioimmunotherapy for early stage (stages I/ II) diffuse large B-cell non-Hodgkin lymphoma: ECOG3402.
- Published in:
- British Journal of Haematology, 2015, v. 170, n. 5, p. 679, doi. 10.1111/bjh.13493
- By:
- Publication type:
- Article
Lines of therapy before autologous stem cell transplant and CAR‐T affect outcomes in aggressive Non‐Hodgkin's lymphoma.
- Published in:
- American Journal of Hematology, 2021, v. 96, n. 10, p. E386, doi. 10.1002/ajh.26293
- By:
- Publication type:
- Article
Acute neuropathies after peripheral blood stem cell and bone marrow transplantation.
- Published in:
- Muscle & Nerve, 2003, v. 28, n. 6, p. 733, doi. 10.1002/mus.10485
- By:
- Publication type:
- Article
AMD3100 Affects Autograft Lymphocyte Collection and Progression-Free Survival After Autologous Stem Cell Transplantion in Non-Hodgkin Lymphoma.
- Published in:
- Clinical Lymphoma & Myeloma, 2007, v. 7, n. 4, p. 315
- By:
- Publication type:
- Article
Peripheral blood stem cell transplant for POEMS syndrome is associated with high rates of engraftment syndrome.
- Published in:
- European Journal of Haematology, 2008, v. 80, n. 5, p. 397, doi. 10.1111/j.1600-0609.2008.01037.x
- By:
- Publication type:
- Article
A pilot study of epratuzumab and rituximab in combination with cyclophosphamide, doxorubicin, vincristine, and prednisone chemotherapy in patients with previously untreated, diffuse large B-cell lymphoma.
- Published in:
- Cancer (0008543X), 2006, v. 107, n. 12, p. 2826, doi. 10.1002/cncr.22342
- By:
- Publication type:
- Article
High-dose intravenous methotrexate followed by autologous stem cell transplantation as a potentially effective therapy for neurolymphomatosis.
- Published in:
- Cancer (0008543X), 2004, v. 100, n. 11, p. 2403
- By:
- Publication type:
- Article
Leukemic High Grade B Cell Lymphoma is Associated With MYC Translocation, Double Hit/Triple Hit Status, Transformation, and CNS Disease Risk: The Mayo Clinic Experience.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2022, v. 22, n. 8, p. e815, doi. 10.1016/j.clml.2022.04.009
- By:
- Publication type:
- Article
Impact of Cell of Origin on Outcomes After Autologous Hematopoietic Cell Transplant in Diffuse Large B-Cell Lymphoma.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2022, v. 22, n. 2, p. e89, doi. 10.1016/j.clml.2021.08.011
- By:
- Publication type:
- Article
PET2 response associated with survival in newly diagnosed diffuse large B-cell lymphoma: results of two independent prospective cohorts.
- Published in:
- Blood Cancer Journal, 2022, v. 12, n. 5, p. 1, doi. 10.1038/s41408-022-00649-x
- By:
- Publication type:
- Article
Lenalidomide in combination with R-CHOP produces high response rates and progression-free survival in new, untreated diffuse large B-cell lymphoma transformed from follicular lymphoma: results from the Phase 2 MC078E study.
- Published in:
- Blood Cancer Journal, 2021, v. 11, n. 9, p. 1, doi. 10.1038/s41408-021-00542-z
- By:
- Publication type:
- Article
Hypomagnesemia at the time of autologous stem cell transplantation for patients with diffuse large B-cell lymphoma is associated with an increased risk of failure.
- Published in:
- Blood Cancer Journal, 2021, v. 11, n. 3, p. 1, doi. 10.1038/s41408-021-00452-0
- By:
- Publication type:
- Article
Food-frequency questionnaire-based estimates of total antioxidant capacity and risk of non-Hodgkin lymphoma.
- Published in:
- International Journal of Cancer, 2012, v. 131, n. 5, p. 1158, doi. 10.1002/ijc.26491
- By:
- Publication type:
- Article
Hematopoietic stem cells from poor and good mobilizers are qualitatively equivalent.
- Published in:
- Transfusion, 2012, v. 52, n. 3, p. 542, doi. 10.1111/j.1537-2995.2011.03286.x
- By:
- Publication type:
- Article
Outcomes in primary cutaneous diffuse large B‐cell lymphoma, leg type.
- Published in:
- Hematological Oncology, 2021, v. 39, n. 5, p. 658, doi. 10.1002/hon.2919
- By:
- Publication type:
- Article
Characteristics of late transplant‐associated thrombotic microangiopathy in patients who underwent allogeneic hematopoietic stem cell transplantation.
- Published in:
- American Journal of Hematology, 2020, v. 95, n. 10, p. 1170, doi. 10.1002/ajh.25922
- By:
- Publication type:
- Article
Impact of MYD88<sup>L265P</sup> mutation status on histological transformation of Waldenström Macroglobulinemia.
- Published in:
- American Journal of Hematology, 2020, v. 95, n. 3, p. 274, doi. 10.1002/ajh.25697
- By:
- Publication type:
- Article
Detection of extranodal and spleen involvement by FDG‐PET imaging predicts adverse survival in untreated follicular lymphoma.
- Published in:
- American Journal of Hematology, 2019, v. 94, n. 7, p. 786, doi. 10.1002/ajh.25493
- By:
- Publication type:
- Article
Role of systemic high‐dose methotrexate and combined approaches in the management of vitreoretinal lymphoma: A single center experience 1990‐2018.
- Published in:
- American Journal of Hematology, 2019, v. 94, n. 3, p. 291, doi. 10.1002/ajh.25350
- By:
- Publication type:
- Article
Efficacy of the oral mTORC1 inhibitor everolimus in relapsed or refractory indolent lymphoma.
- Published in:
- American Journal of Hematology, 2017, v. 92, n. 5, p. 448, doi. 10.1002/ajh.24671
- By:
- Publication type:
- Article
Personalized risk prediction for event-free survival at 24 months in patients with diffuse large B-cell lymphoma.
- Published in:
- American Journal of Hematology, 2016, v. 91, n. 2, p. 179, doi. 10.1002/ajh.24223
- By:
- Publication type:
- Article
Elevated monoclonal and polyclonal serum immunoglobulin free light chain as prognostic factors in B- and T-cell non- Hodgkin lymphoma.
- Published in:
- American Journal of Hematology, 2014, v. 89, n. 12, p. 1116, doi. 10.1002/ajh.23839
- By:
- Publication type:
- Article
Safety and efficacy of upfront plerixafor + G-CSF versus placebo + G-CSF for mobilization of CD34<sup>+</sup> hematopoietic progenitor cells in patients ≥60 and <60 years of age with non-Hodgkin's lymphoma or multiple myeloma.
- Published in:
- American Journal of Hematology, 2013, v. 88, n. 12, p. 1017, doi. 10.1002/ajh.23561
- By:
- Publication type:
- Article
A phase I trial of immunostimulatory CpG 7909 oligodeoxynucleotide and <sup>90</sup>yttrium ibritumomab tiuxetan radioimmunotherapy for relapsed B-cell non-Hodgkin lymphoma.
- Published in:
- American Journal of Hematology, 2013, v. 88, n. 7, p. 589, doi. 10.1002/ajh.23460
- By:
- Publication type:
- Article
Hematopoietic recovery kinetics predicts for poor CD34+ cell mobilization after cyclophosphamide chemotherapy in multiple myeloma.
- Published in:
- American Journal of Hematology, 2012, v. 87, n. 1, p. 1, doi. 10.1002/ajh.22179
- By:
- Publication type:
- Article
Predicting survival for diffuse large B-cell lymphoma patients using baseline neutrophil/lymphocyte ratio.
- Published in:
- American Journal of Hematology, 2010, v. 85, n. 11, p. 896, doi. 10.1002/ajh.21849
- By:
- Publication type:
- Article
A Phase II study of <sup>153</sup>Sm-EDTMP and high-dose melphalan as a peripheral blood stem cell conditioning regimen in patients with multiple myeloma.
- Published in:
- American Journal of Hematology, 2010, v. 85, n. 6, p. 409, doi. 10.1002/ajh.21696
- By:
- Publication type:
- Article
A Phase II trial of the oral mTOR inhibitor everolimus in relapsed Hodgkin lymphoma.
- Published in:
- American Journal of Hematology, 2010, v. 85, n. 5, p. 320, doi. 10.1002/ajh.21664
- By:
- Publication type:
- Article
Acute weight gain and diastolic dysfunction as a potent risk complex for post stem cell transplant atrial fibrillation.
- Published in:
- American Journal of Hematology, 2009, v. 84, n. 8, p. 499, doi. 10.1002/ajh.21459
- By:
- Publication type:
- Article
Day 100 Recovery of Absolute Number of Inhibitory KIR2DL2 and Activating NKp30 Natural Killer Cells Predicts Survival Post-Autologous Stem Cell Transplantation in Lymphomas.
- Published in:
- Biomedicines, 2024, v. 12, n. 8, p. 1808, doi. 10.3390/biomedicines12081808
- By:
- Publication type:
- Article
Infused autograft lymphocyte to monocyte ratio predicts survival in classical Hodgkin lymphoma.
- Published in:
- Journal of Blood Medicine, 2015, v. 6, p. 45, doi. 10.2147/JBM.S75784
- By:
- Publication type:
- Article
Infused autograft lymphocyte-to-monocyte ratio and survival in T-cell lymphoma postautologous peripheral blood hematopoietic stem cell transplantation.
- Published in:
- Journal of Hematology & Oncology, 2015, v. 8, n. 1, p. 1, doi. 10.1186/s13045-015-0178-5
- By:
- Publication type:
- Article
Infused autograft lymphocyte-to-monocyte ratio and survival in T-cell lymphoma postautologous peripheral blood hematopoietic stem cell transplantation
- Published in:
- Journal of Hematology & Oncology, 2015, v. 8, n. 1, p. 80, doi. 10.1186/s13045-015-0178-5
- By:
- Publication type:
- Article
The Treatment of Recurrent/Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL) With Everolimus Results in Clinical Responses and Mobilization of CLL Cells Into the Circulation.
- Published in:
- Cancer (0008543X), 2010, v. 116, n. 9, p. 2201, doi. 10.1002/cncr.25005
- By:
- Publication type:
- Article
Peripheral blood lymphocyte/monocyte ratio at diagnosis and survival in nodular lymphocyte-predominant Hodgkin lymphoma.
- Published in:
- British Journal of Haematology, 2012, v. 157, n. 3, p. 321, doi. 10.1111/j.1365-2141.2012.09067.x
- By:
- Publication type:
- Article
Effect of the dose per body weight of conditioning chemotherapy on severity of mucositis and risk of relapse after autologous haematopoietic stem cell transplantation in relapsed diffuse large B cell lymphoma.
- Published in:
- British Journal of Haematology, 2008, v. 143, n. 2, p. 268, doi. 10.1111/j.1365-2141.2008.07342.x
- By:
- Publication type:
- Article
Germinal center B (GCB) and non-GCB cell-like diffuse large B cell lymphomas have similar outcomes following autologous haematopoietic stem cell transplantation.
- Published in:
- British Journal of Haematology, 2008, v. 142, n. 3, p. 404, doi. 10.1111/j.1365-2141.2008.07207.x
- By:
- Publication type:
- Article
Absolute lymphocyte count predicts therapeutic efficacy of rituximab therapy in follicular lymphomas.
- Published in:
- British Journal of Haematology, 2007, v. 137, n. 5, p. 409, doi. 10.1111/j.1365-2141.2007.06596.x
- By:
- Publication type:
- Article
Absolute lymphocyte count predicts overall survival in follicular lymphomas.
- Published in:
- British Journal of Haematology, 2006, v. 134, n. 6, p. 596, doi. 10.1111/j.1365-2141.2006.06232.x
- By:
- Publication type:
- Article
Timing of autologous stem cell transplantation from last chemotherapy affects lymphocyte collection and survival in non-Hodgkin lymphoma.
- Published in:
- British Journal of Haematology, 2006, v. 133, n. 6, p. 628, doi. 10.1111/j.1365-2141.2006.06088.x
- By:
- Publication type:
- Article
Early lymphocyte recovery post-autologous haematopoietic stem cell transplantation is associated with better survival in Hodgkin's disease.
- Published in:
- British Journal of Haematology, 2002, v. 117, n. 3, p. 629, doi. 10.1046/j.1365-2141.2002.03478.x
- By:
- Publication type:
- Article
Loss of CD20 expression following treatment with rituximab (chimaeric monoclonal anti-CD20): a retrospective cohort analysis.
- Published in:
- British Journal of Haematology, 2001, v. 114, n. 4, p. 881, doi. 10.1046/j.1365-2141.2001.03019.x
- By:
- Publication type:
- Article
Long-term outcome of patients surviving for more than ten years following treatment for acute leukaemia.
- Published in:
- British Journal of Haematology, 2001, v. 113, n. 2, p. 443, doi. 10.1046/j.1365-2141.2001.02788.x
- By:
- Publication type:
- Article
Interleukin-15 Affects Patient Survival through Natural Killer Cell Recovery after Autologous Hematopoietic Stem Cell Transplantation for Non-Hodgkin Lymphomas.
- Published in:
- Clinical & Developmental Immunology, 2010, p. 1, doi. 10.1155/2010/914945
- By:
- Publication type:
- Article
Day 100 Natural Killer Cell/CD14+HLA‐DR<sup>DIM</sup> ratio and survival in lymphoma post‐autologous peripheral blood hematopoietic stem cell transplantation.
- Published in:
- Clinical Transplantation, 2024, v. 38, n. 1, p. 1, doi. 10.1111/ctr.15211
- By:
- Publication type:
- Article
Cohort Profile: The Lymphoma Specialized Program of Research Excellence (SPORE) Molecular Epidemiology Resource (MER) Cohort Study.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Day 100 Peripheral Blood Absolute Lymphocyte/Monocyte Ratio and Survival in Classical Hodgkin's Lymphoma Postautologous Peripheral Blood Hematopoietic Stem Cell Transplantation.
- Published in:
- Bone Marrow Research, 2013, p. 1, doi. 10.1155/2013/658371
- By:
- Publication type:
- Article